ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ResMed's operating cash flow for the twelve months ending Jun 30, 2026 was $1.81B, up 3.1% year over year. For fiscal 2026 it was $1.81B, up 3.1% from the year before. Over ten years it grew 12.7% a year on average. The highest annual figure on record is $1.81B in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.81B | +3.1% |
| FY2025 | Jun 30, 2025 | $1.75B | +25.0% |
| FY2024 | Jun 30, 2024 | $1.40B | +102.1% |
| FY2023 | Jun 30, 2023 | $693.30M | +97.4% |
| FY2022 | Jun 30, 2022 | $351.15M | -52.3% |
| FY2021 | Jun 30, 2021 | $736.72M | -8.2% |
| FY2020 | Jun 30, 2020 | $802.26M | +74.8% |
| FY2019 | Jun 30, 2019 | $459.05M | -9.1% |
| FY2018 | Jun 30, 2018 | $505.03M | +22.0% |
| FY2017 | Jun 30, 2017 | $414.05M | -24.4% |
| FY2016 | Jun 30, 2016 | $547.93M | +43.0% |
| FY2015 | Jun 30, 2015 | $383.18M | -2.1% |
| FY2014 | Jun 30, 2014 | $391.27M | -2.9% |
| FY2013 | Jun 30, 2013 | $402.82M | +5.1% |
| FY2012 | Jun 30, 2012 | $383.16M | +35.3% |
| FY2011 | Jun 30, 2011 | $283.19M | +50.5% |
| FY2010 | Jun 30, 2010 | $188.21M | -21.2% |
| FY2009 | Jun 30, 2009 | $238.88M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $454.63M | -15.6% |
| Q3 FY2026 | Mar 31, 2026 | $554.13M | -4.2% |
| Q2 FY2026 | Dec 31, 2025 | $339.75M | +10.1% |
| Q1 FY2026 | Sep 30, 2025 | $457.32M | +40.5% |
| Q4 FY2025 | Jun 30, 2025 | $538.77M | +22.4% |
| Q3 FY2025 | Mar 31, 2025 | $578.66M | +43.9% |
| Q2 FY2025 | Dec 31, 2024 | $308.62M | +13.1% |
| Q1 FY2025 | Sep 30, 2024 | $325.54M | +13.7% |
| Q4 FY2024 | Jun 30, 2024 | $440.11M | +85.4% |
| Q3 FY2024 | Mar 31, 2024 | $402.03M | +42.3% |
| Q2 FY2024 | Dec 31, 2023 | $272.83M | +112.1% |
| Q1 FY2024 | Sep 30, 2023 | $286.28M | +541.0% |
| Q4 FY2023 | Jun 30, 2023 | $237.44M | +198.7% |
| Q3 FY2023 | Mar 31, 2023 | $282.57M | +140.6% |
| Q2 FY2023 | Dec 31, 2022 | $128.64M | -41.5% |
| Q1 FY2023 | Sep 30, 2022 | $44.66M | – |
| Q4 FY2022 | Jun 30, 2022 | $79.49M | -64.9% |
| Q3 FY2022 | Mar 31, 2022 | $117.44M | -40.2% |
| Q2 FY2022 | Dec 31, 2021 | $219.88M | +29.4% |
| Q1 FY2022 | Sep 30, 2021 | -$65.66M | -145.6% |
| Q4 FY2021 | Jun 30, 2021 | $226.53M | -31.4% |
| Q3 FY2021 | Mar 31, 2021 | $196.28M | -18.1% |
| Q2 FY2021 | Dec 31, 2020 | $169.92M | +143.0% |
| Q1 FY2021 | Sep 30, 2020 | $144.00M | -11.3% |
| Q4 FY2020 | Jun 30, 2020 | $330.27M | +132.9% |
| Q3 FY2020 | Mar 31, 2020 | $239.70M | +71.6% |
| Q2 FY2020 | Dec 31, 2019 | $69.93M | -46.0% |
| Q1 FY2020 | Sep 30, 2019 | $162.36M | +237.4% |
| Q4 FY2019 | Jun 30, 2019 | $141.82M | +9.6% |
| Q3 FY2019 | Mar 31, 2019 | $139.65M | -6.3% |
| Q2 FY2019 | Dec 31, 2018 | $129.47M | -2.3% |
| Q1 FY2019 | Sep 30, 2018 | $48.12M | -48.8% |
| Q4 FY2018 | Jun 30, 2018 | $129.42M | -7.8% |
| Q3 FY2018 | Mar 31, 2018 | $149.08M | +120.5% |
| Q2 FY2018 | Dec 31, 2017 | $132.55M | +10.6% |
| Q1 FY2018 | Sep 30, 2017 | $93.98M | +9.0% |
| Q4 FY2017 | Jun 30, 2017 | $140.31M | – |
| Q3 FY2017 | Mar 31, 2017 | $67.60M | – |
| Q2 FY2017 | Dec 31, 2016 | $119.90M | – |
| Q1 FY2017 | Sep 30, 2016 | $86.24M | – |